Cargando…
Polymyxin B-Induced Skin Hyperpigmentation
Polymyxin B-induced skin hyperpigmentation is a rare adverse drug reaction (ADR). In this report, we present the case of a patient who underwent an abscess resection with right epididymitis, in which a multidrug-resistant Klebsiella pneumoniae infection (KPI) is formed. The patient was treated with...
Autores principales: | Wen, Xueke, Luo, Chunliu, Lyu, Weitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519980/ https://www.ncbi.nlm.nih.gov/pubmed/33014066 http://dx.doi.org/10.1155/2020/6461329 |
Ejemplares similares
-
Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review
por: Zheng, Guanhao, et al.
Publicado: (2018) -
Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit?
por: Lu, Cuicui, et al.
Publicado: (2020) -
Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016) -
Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
por: Prka, Zeljko, et al.
Publicado: (2012) -
Levetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect
por: Algahtani, Hussein, et al.
Publicado: (2017)